Literature DB >> 15946145

Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa.

Masaaki Kodama1, Toshio Fujioka, Kazunari Murakami, Tadayoshi Okimoto, Ryugo Sato, Koichiro Watanabe, Masaru Nasu.   

Abstract

BACKGROUND: Although Helicobacter pylori has been regarded as a pathogen of gastric cancer, the mechanism by which H. pylori is involved in gastric carcinogenesis remains unknown. To clarify the role of H. pylori in carcinogenesis, the expression of tumor suppressor p53 and its regulator multiple double minute 2 (MDM2) in gastric mucosa were examined before and after H. pylori eradication.
METHODS: Biopsy specimens were obtained from 31 patients with H. pylori-infected gastric mucosa. Endoscopic biopsies were repeated 6 months after successful eradication. In addition, biopsy specimens from 12 patients with non-infected gastric mucosa were obtained. Immunohistochemical analysis was performed on the specimens using primary antibodies specific for p53 and MDM2.
RESULTS: Six months after H. pylori eradication, labeling indices for p53 were significantly reduced in the gastric corpus (2.3-fold; P < 0.01), and in the gastric antrum (2.0-fold; P < 0.01). Similarly, labeling indices for MDM2 were significantly reduced in the corpus (1.7-fold; P < 0.01), and in the antrum (3.5-fold; P < 0.01). In the non-infected group, labeling indices for p53 and MDM2 in the gastric mucosa were significantly lower (P < 0.01) than those of the H. pylori-infected group.
CONCLUSION: A significant increase is shown in p53 and MDM2 expression in H. pylori-infected gastric mucosa as compared to normal gastric mucosa; but successful eradication of H. pylori dramatically reduced the p53 and MDM2 levels. Therefore, H. pylori infection may be associated with alteration of cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946145     DOI: 10.1111/j.1440-1746.2005.03880.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis.

Authors:  Masaaki Kodama; Kazunari Murakami; Ryugo Sato; Tadayoshi Okimoto; Akira Nishizono; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells.

Authors:  Jinxiong Wei; Toni A Nagy; Anna Vilgelm; Elena Zaika; Seth R Ogden; Judith Romero-Gallo; Maria B Piazuelo; Pelayo Correa; Mary K Washington; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

3.  Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Masahiro Uchida; Takashi Abe; Seiji Shiota; Yoshifumi Nakagawa; Kazuhiro Mizukami; Toshio Fujioka
Journal:  J Gastroenterol       Date:  2011-12-06       Impact factor: 7.527

4.  Prognostic significance of p53 protein expression in early gastric cancer.

Authors:  Andrea Rodrigues Gonçalves; Antonio Jose Vasconcellos Carneiro; Ivanir Martins; Paulo Antonio Silvestre de Faria; Maria Aparecida Ferreira; Eduardo Linhares Riello de Mello; Homero Soares Fogaça; Celeste Carvalho Siqueira Elia; Heitor Siffert Pereira de Souza
Journal:  Pathol Oncol Res       Date:  2010-11-30       Impact factor: 3.201

Review 5.  Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis.

Authors:  Kazunari Murakami; Masaaki Kodama; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

6.  Helicobacter pylori Infection Activates the Akt-Mdm2-p53 Signaling Pathway in Gastric Epithelial Cells.

Authors:  Xu Shu; Zhen Yang; Zhong-Hua Li; Lian Chen; Xiao-Dong Zhou; Yong Xie; Nong-Hua Lu
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

7.  Expression of mutant type-p53 products in H pylori-associated chronic gastritis.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Koichiro Watanabe; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Meta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk.

Authors:  Weifeng Chen; Qianlan Wu; Hongbo Ren
Journal:  Biomed Rep       Date:  2013-10-07

9.  The Expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-Infected Intestinal Metaplasia and Gastric Cancer.

Authors:  Noriko Nakajima; Yoko Ito; Kiyoshi Yokoyama; Akitake Uno; Noriko Kinukawa; Norimichi Nemoto; Mitsuhiko Moriyama
Journal:  J Clin Biochem Nutr       Date:  2009-02-28       Impact factor: 3.114

10.  A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.

Authors:  Xiaolin Pan; Yuqin Li; Jin Feng; Xiaoyong Wang; Bo Hao; Ruihua Shi; Guoxin Zhang
Journal:  BMC Cancer       Date:  2013-03-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.